Compound Edaravone Injection for Acute Ischemic Stroke

Clinical trial NCT01929096 · COMPLETED

Trial details

NCT number: NCT01929096
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2013-08-01
Primary completion: 2014-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.